Publication | Open Access
Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria
13
Citations
38
References
2021
Year
The impact of apoC-III on MACE risk and mortality is restricted to those with albuminuria among individuals with type 1 diabetes. This study also revealed that apoC-III predicts DKD progression, independent of the initial DKD category.
| Year | Citations | |
|---|---|---|
Page 1
Page 1